ChemPartner Competitors and Similar CompaniesClear all
Eurofins's competitors and similar companies include Corcept Therapeutics.
 Corcept Therapeutics Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators. | ||
Founding Date | Founding Date 1987 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Redwood City, US HQ | |
Employees | Employees 65,694 | Employees 50042% increase |
Valuation ($) | Valuation ($) 9.5 b | Valuation ($) 5 b |
Financial | ||
Revenue (est.) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) $761.4m (FY, 2025) |
Cost of goods | Cost of goods €2.3b (FY, 2025) | Cost of goods $13m (FY, 2025) |
Gross profit | Gross profit €5b (FY, 2025) | Gross profit $748.4m (FY, 2025) |
Net income | Net income €473m (FY, 2025) | Net income $99.7m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 80.1m |
For sources of this data, please see the company profile
View Company Profiles
Corcept Therapeutics
HQ
Redwood City, US
Employees
500↑ 42% increase
Corcept Therapeutics is a company that specializes in the research and development of cortisol modulators.
View company